There are many ways to modulate the immune response in a therapeutic setting. Drugs that target the proinflammatory mediator IL-1, for instance, can counteract disease in certain types of ...

Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying $20 million for the buy-in as part of ...

None of the immune-modulating drugs approved to treat ulcerative colitis – even biosimilars – are priced low enough to be cost-effective, says the Institute for Clinical and Economic Review ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

A study led by TUM researchers finds that cystic fibrosis alters immune cells early in life, likely before birth. These ...

However, considerable opportunities still exist to develop innate immune-modulating drugs, especially macrophage-targeted drugs, and this is where United Immunity could make its mark.

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

could be considered an autoinflammatory or autoimmune disease and be successfully treated with immune modulator drugs, Clardy said. More broadly, revealing how a bacterial product can alter human ...

The associations make sense, particularly because GLP-1 drugs have unexpected effects on modulating immune functions linked to obesity-associated cancers. “The protective effects of GLP-1s ...